Technomed ( India ) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 38 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.40 M
as on 02-07-2024
- Revenue 90.12%
(FY 2023)
- Profit 54.63%
(FY 2023)
- Ebitda 98.71%
(FY 2023)
- Net Worth 25.56%
(FY 2023)
- Total Assets 33.95%
(FY 2023)
About Technomed ( India )
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.40 M.
Samarth Sapra, Renu Sapra, and Deepak Sapra serve as directors at the Company.
- CIN/LLPIN
U74899DL1986PTC023774
- Company No.
023774
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 1986
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Technomed ( India ) Private Limited offer?
Technomed ( India ) Private Limited offers a wide range of products and services, including Bandages & Dressing Disposables, Bandages, Orthopedic Equipment & Supplies, Lower Body Orthotic Device, Medical Surgery & Treatment Centres, Medical Treatment Services, Hospital & Medical Lights, Surgical Light, Physiotherapy & Rehab Aids, Compression Stockings.
Who are the key members and board of directors at Technomed ( India )?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samarth Sapra  | Director | 02-Jan-2020 | Current |
| Renu Sapra | Director | 05-Jul-1996 | Current |
| Deepak Sapra | Director | 04-Dec-1990 | Current |
Financial Performance of Technomed ( India ).
Technomed ( India ) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 90.12% increase. The company also saw a substantial improvement in profitability, with a 54.63% increase in profit. The company's net worth Soared by an impressive increase of 25.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Technomed ( India )?
In 2023, Technomed ( India ) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Sep 2022 | ₹0.40 M | Open |
How Many Employees Work at Technomed ( India )?
Unlock and access historical data on people associated with Technomed ( India ), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Technomed ( India ), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Technomed ( India )'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
